Skip to main content
SpringerLink
Log in

Serum testosterone and obesity in prostate cancer biology: a call for health promotion in the ageing male

  • Point of View
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics. CA Cancer J Clin 69:7–34

    Article  Google Scholar 

  2. Huggins C, Hodges CV (1972) Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 22:232–240

    Article  CAS  Google Scholar 

  3. Antonelli A, Palumbo C, Veccia A et al (2018) Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review. Minerva Urol Nefrol 70:370–379

    PubMed  Google Scholar 

  4. Loughlin KR (2016) The testosterone conundrum: the putative relationship between testosterone levels and prostate cancer. Urol Oncol 34:482.e1–482.e4

    Article  CAS  Google Scholar 

  5. Gapstur SM, Gann PH, Kopp P et al (2002) Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Prevent Biomark 11:1041–1047

    CAS  Google Scholar 

  6. Wang K, Chen X, Bird VY et al (2017) Association between age-related reductions in testosterone and risk of prostate cancer—an analysis of patients' data with prostatic diseases. Int J Cancer 141:1783–1793

    Article  CAS  Google Scholar 

  7. Klap J, Schmid M, Loughlin KR (2015) The relationship between total testosterone levels and prostate cancer: a review of the continuing controversy. J Urol 193:403–414

    Article  CAS  Google Scholar 

  8. Salonia A, Abdollah F, Capitanio U et al (2012) Serum sex steroids depict a nonlinear u-shaped association with high-risk prostate cancer at radical prostatectomy. Clin Cancer Res 18:3648–3657

    Article  CAS  Google Scholar 

  9. Schatzl G, Madersbacher S, Haitel A et al (2003) Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer. J Urol 169:1312–1315

    Article  CAS  Google Scholar 

  10. Page ST, Lin DW, Mostaghel EA et al (2006) Persistent intraprostatic androgen concentrations after medical castration in healthy men. J Clin Endocrinol Metab 91:3850–3856

    Article  CAS  Google Scholar 

  11. Morgentaler A, Traish AM (2009) Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol 55:310–320

    Article  Google Scholar 

  12. Bell MA, Campbell JD, Joice G et al (2018) Shifting the paradigm of testosterone replacement therapy in prostate cancer. World J Men's Health 36:103–109

    Article  Google Scholar 

  13. Golan R, Scovell JM, Ramasamy R (2015) Age-related testosterone decline is due to waning of both testicular and hypothalamic–pituitary function. Aging Male 18:201–204

    Article  Google Scholar 

  14. Bandini M, Gandaglia G, Briganti A (2017) Obesity and prostate cancer. Curr Opin Urol 27:415–421

    Article  Google Scholar 

  15. Antonelli A, Palumbo C, Noale M et al (2019) Impact of surgical approach on patient-reported outcomes after radical prostatectomy: a propensity score-weighted analysis from a multicenter, prospective, observational study (The Pros-IT CNR Study). Urol Int 103:8–18

    Article  Google Scholar 

  16. Porcaro AB, Tafuri A, Sebben M et al (2020) High body mass index predicts multiple prostate cancer lymph node metastases after radical prostatectomy and extended pelvic lymph node dissection. Asian J Androl 22:323

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, Piazzale Stefani 1, 37126, Verona, Italy

    Alessandro Tafuri, Antonio B. Porcaro, Filippo Migliorini, Maria Angela Cerruto & Alessandro Antonelli

  2. Department of Neuroscience, Imaging and Clinical Science, Physiology and Physiopathology Division, “G. D’Annunzio” University, Chieti, Italy

    Alessandro Tafuri & Vittore Verratti

  3. USC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California (USC), Los Angeles, CA, USA

    Aliasger Shakir

  4. Department of Pathology, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy

    Matteo Brunelli

Authors
  1. Alessandro Tafuri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonio B. Porcaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aliasger Shakir
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Filippo Migliorini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vittore Verratti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Matteo Brunelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Maria Angela Cerruto
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Alessandro Antonelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alessandro Antonelli.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethical statement

This article does not contain any studies with human participants or animals.

Informed consent

Informed consent does not apply to this submission.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tafuri, A., Porcaro, A.B., Shakir, A. et al. Serum testosterone and obesity in prostate cancer biology: a call for health promotion in the ageing male. Aging Clin Exp Res 33, 1399–1401 (2021). https://doi.org/10.1007/s40520-020-01625-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-020-01625-w

Search

Navigation